# Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors

> **NCT01032200** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 54 (actual)

## Conditions studied

- Brain Tumors
- Nervous System Tumors
- Cognition Disorders
- Fatigue

## Interventions

- **DRUG:** Armodafinil
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01032200
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08-01
- **Primary completion:** 2013-01-08
- **Final completion:** 2013-01-08
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2021-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01032200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01032200, "Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01032200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*